Wang, Erica B.
Kaur, Ramanjot
Nguyen, Julie
Ho, Derek
Austin, Evan
Maverakis, Emanual
Li, Chin-Shang
Hwang, Samuel T.
Isseroff, R. Rivkah
Jagdeo, Jared
Funding for this research was provided by:
National Institute of General Medical Sciences (K23GM117309)
Article History
Received: 27 March 2018
Accepted: 4 March 2019
First Online: 20 March 2019
Ethics approval and consent to participate
: Study approval was obtained from the Institutional Review Board (IRB) Human Studies Subcommittee at the Sacramento VA Medical Center (reference []–01-00804) on January 26, 2018. Any protocol amendments will require IRB approval. Routine auditing of this study will be performed in accordance with VA guidelines. The protocol identification number on ClinicalTrials.gov is NCT03433222. This study will be conducted in accordance with medical professional codex and the Helsinki Declaration as of 1996 as well as Data Security Laws and Good Clinical Practice criteria. Written IRB-approved informed consent will be obtained from all subjects prior to enrollment, and subjects will be given adequate time to declare whether they wish to participate in this study before signing the consent form. Study participation is voluntary and can be withdrawn at any time without provision of reason and without negative consequences for future medical care.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.